Antimicrobials | Breakpoint by CLSI | Susceptibility | MIC | ||||
---|---|---|---|---|---|---|---|
 |  | S(%) | I(%) | R(%) | MIC50 (mg/l) | MIC90 (mg/l) | Range (mg/l) |
Penicillin | 0.12/0.25–2/4 | 100 | 0 | 0 | 0.125 | 0.125 | < 0.03–0.12 |
Amoxicillin | 0.25/0.5–4/8 | 100 | 0 | 0 | < 0.25 | < 0.25 | all < 0.25 |
Cefotaxime | 1/2/4 | 100 | 0 | 0 | < 0.5 | < 0.5 | all < 0.5 |
Erythromycin | 0.25/0.5/1 | 11.1(5/45) | 0 | 88.9(40/45) | > 4 | > 4 | 0.0625- > 4 |
Clindamycin | 0.25/0.5/1 | 11.1(5/45) | 0 | 88.9(40/45) | > 4 | > 4 | 0.0625~ > 4 |
Levofloxacin | 2/4/8 | 73.3(33/45) | 15.6(7/45) | 11.1(5/45) | 2 | 4 | 1~ > 4 |
Moxifloxacin | 1/2/4 | 88.9(40/45) | 2.2(1/45) | 8.9(4/45) | 0.5 | 1 | ≤0.25~ > 2 |
Tetracycline | 2/4/8 | 4.4(2/45) | 2.2(1/45) | 93.3(42/45) | > 8 | > 8 | 0.0625~ > 4 |
Linezolid | 2 | 100 | 0 | 0 | ≤1 | 2 | ≤1~2 |
Meropenem | 0.5 | 100 | 0 | 0 | ≤0.0625 | ≤0.0625 | ≤0.0625 |
Vancomycin | 1 | 100 | 0 | 0 | ≤0.25 | ≤0.25 | ≤0.25–1 |